{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:56:47Z","timestamp":1791647807371,"version":"4.3.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T00:00:00Z","timestamp":1570924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ijcard.2019.09.053","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T09:53:57Z","timestamp":1571565237000},"page":"103-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Coagulation factors and fibrinolytic activity in the left atrial appendage and other heart chambers in patients with atrial fibrillation: is there a local intracardiac prothrombotic state? (HEART-CLOT study)"],"prefix":"10.1016","volume":"301","author":[{"given":"Krzysztof","family":"Bartus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslaw","family":"Litwinowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Natorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Zabczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguslaw","family":"Kapelak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanunjaya","family":"Lakkireddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijcard.2019.09.053_bib1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3109\/07853890.2010.507601","article-title":"Genetic polymorphisms and atrial fibrillation: insights into the prothrombotic state and thromboembolic risk","volume":"42","author":"Lopez-Cuenca","year":"2010","journal-title":"Ann. Med."},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.053_bib2","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.5603\/KP.a2018.0202","article-title":"Recurrence of atrial fibrillation ten years after thoracoscopic transdiaphragmatic epicardial radiofrequency ablation","volume":"76","author":"Bryndza","year":"2018","journal-title":"Kardiol. Pol."},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.053_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/euhj.1999.2581","article-title":"A clinical appraisal of left atrial function","volume":"22","author":"Stefanadis","year":"2001","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.ijcard.2019.09.053_bib4","first-page":"2719","article-title":"Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.053_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.20452\/pamw.4165","article-title":"Plasma fibrin clot structure and thromboembolism: clinical implications","volume":"127","author":"Undas","year":"2017","journal-title":"Pol Arch Intern Med."},{"issue":"14","key":"10.1016\/j.ijcard.2019.09.053_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0195-668X(03)00239-2","article-title":"Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation","volume":"24","author":"Roldan","year":"2003","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.053_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000319626","article-title":"D-dimer levels in combination with clinical risk factors can effectively predict subsequent thromboembolic events in patients with atrial fibrillation during oral anticoagulant therapy","volume":"117","author":"Sadanaga","year":"2010","journal-title":"Cardiology"},{"issue":"6","key":"10.1016\/j.ijcard.2019.09.053_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0002-8703(98)70149-8","article-title":"Hypofibrinolysis in atrial fibrillation","volume":"136","author":"Rold\u00e1n","year":"1998","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.ijcard.2019.09.053_bib9","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1161\/01.ATV.0000228844.65168.d1","article-title":"Thrombin-cofactor interactions: structural insights into regulatory mechanisms","volume":"26","author":"Adams","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.ijcard.2019.09.053_bib10","doi-asserted-by":"crossref","first-page":"400","DOI":"10.20452\/pamw.1101","article-title":"Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation","volume":"121","author":"Zabczyk","year":"2011","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.053_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:THRO.0000024053.45693.fc","article-title":"Atrial fibrillation and hypercoagulability: dependent on clinical factors or\/and on genetic alterations?","volume":"16","author":"Hatzinikolaou-Kotsakou","year":"2003","journal-title":"J. Thromb. Thrombolysis"},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1160\/TH05-02-0093","article-title":"Circulating endothelial cells in atrial fibrillation with and without acute cardiovascular disease","volume":"94","author":"Freestone","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.ijcard.2019.09.053_bib13","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1182\/blood.V95.9.2855.009k02_2855_2859","article-title":"Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis","volume":"95","author":"van Tilburg","year":"2000","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.053_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"Drabik","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2019.09.053_bib15","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2017.05.060","article-title":"Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation","volume":"243","author":"Matusik","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.053_bib16","series-title":"Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation","first-page":"3678017","author":"Toth","year":"2017"},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.053_bib17","first-page":"327","article-title":"Stroke risk reduction after left atrial appendage occlusion in elderly patients with atrial fibrillation: long\u2011term results","volume":"128","author":"Litwinowicz","year":"2018","journal-title":"Pol. Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.053_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/1753-0407.12824","article-title":"Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: long-term results","volume":"11","author":"Litwinowicz","year":"2019","journal-title":"J. Diabetes"},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.053_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208710","article-title":"Long term outcomes after left atrial appendage closure with the LARIAT device\u2014stroke risk reduction over five years follow-up","volume":"13","author":"Litwinowicz","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijcard.2019.09.053_bib20","first-page":"117","article-title":"Atrial natriuretic peptide and brain natriuretic peptide changes after epicardial percutaneous left atrial appendage suture ligation using LARIAT device","volume":"68","author":"Bartus","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.053_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.hrthm.2010.10.040","article-title":"Feasibility of closed-chest ligation of the left atrial appendage in humans","volume":"8","author":"Bartus","year":"2011","journal-title":"Heart Rhythm"},{"issue":"15","key":"10.1016\/j.ijcard.2019.09.053_bib22","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000033221.73082.06","article-title":"Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease","volume":"106","author":"Mills","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.053_bib23","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/jth.14002","article-title":"An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH","volume":"16","author":"Pieters","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2019.09.053_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-0037-1613046","article-title":"Thrombin generation in a reconstituted system: a comment","volume":"87","author":"Hemker","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.053_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-5273(98)00211-3","article-title":"Increased thrombin\u2013antithrombin III complex during an episode of paroxysmal atrial fibrillation","volume":"66","author":"Iga","year":"1998","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2019.09.053_bib26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1253\/circj.CJ-09-0008","article-title":"Coagulation activity is increased in the left atria of patients with paroxysmal atrial fibrillation during the non-paroxysmal period","volume":"73","author":"Motoki","year":"2009","journal-title":"Circ. J."},{"issue":"22","key":"10.1016\/j.ijcard.2019.09.053_bib27","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1161\/01.CIR.0000039327.11661.16","article-title":"Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke","volume":"106","author":"Cai","year":"2002","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.ijcard.2019.09.053_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011269","article-title":"Prognostic value of von Willebrand factor in patients with atrial fibrillation: a meta-analysis","volume":"97","author":"Zhong","year":"2018","journal-title":"Medicine"},{"issue":"38","key":"10.1016\/j.ijcard.2019.09.053_bib29","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.053_bib30","first-page":"385","article-title":"Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms","volume":"111","author":"Cove","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.ijcard.2019.09.053_bib31","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib32","first-page":"435","article-title":"Rapid left atrial appendage thrombus formation before suture ligation with LARIAT","volume":"14","author":"Bartu\u015b","year":"2018","journal-title":"Advances in Interventional Cardiology\/Post\u0119py w Kardiologii Interwencyjnej"},{"issue":"7","key":"10.1016\/j.ijcard.2019.09.053_bib33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/0735-1097(92)90463-W","article-title":"Echocardiographic \"smoke\" is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces","volume":"20","author":"Merino","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2019.09.053_bib34","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.hrthm.2013.01.036","article-title":"Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores","volume":"10","author":"Kimura","year":"2013","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.053_bib35","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1067\/mhj.2000.110284","article-title":"Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study","volume":"140","author":"Goldsmith","year":"2000","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib36","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.2003.015347","article-title":"Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease","volume":"90","author":"Boldt","year":"2004","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.ijcard.2019.09.053_bib37","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/01.STR.0000065431.76788.D9","article-title":"Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?","volume":"34","author":"Marin","year":"2003","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib38","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.96.4.1180","article-title":"Histological substrate of atrial biopsies in patients with lone atrial fibrillation","volume":"96","author":"Frustaci","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.09.053_bib39","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2016.04.005","article-title":"Left atrial appendage ligation with the next generation LARIAT(+) suture delivery device: early clinical experience","volume":"215","author":"Bartus","year":"2016","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2019.09.053_bib40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/jce.13343","article-title":"Anatomical and electrical remodeling with incomplete left atrial appendage ligation: results from the LAALA\u2010AF registry","volume":"28","author":"Turagam","year":"2017","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib41","first-page":"764","article-title":"Anatomic analysis of the left atrial appendage after closure with the LARIAT device","volume":"7","author":"Bartus","year":"2014","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib42","first-page":"438","article-title":"Coronary artery bypass grafting after left atrial appendage ligation\u2013is anti-inflammatory treatment after LARIAT effective?","volume":"14","author":"Bartu\u015b","year":"2018","journal-title":"Post\u0119py Kardiol Interwencyjnej"},{"issue":"3\u20134","key":"10.1016\/j.ijcard.2019.09.053_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000500850","article-title":"Left Atrial Appendage Occlusion for Secondary Stroke Prevention in Patients with Atrial Fibrillation: Long-Term Results","volume":"47","author":"Litwinowicz","year":"2019","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.09.053_bib44","article-title":"Reduction in risk of stroke and bleeding after left atrial appendage closure with LARIAT device in patients with increased risk of stroke and bleeding: long term results","author":"Litwinowicz","year":"2019","journal-title":"Cathet. Cardiovasc. Interv."},{"issue":"4","key":"10.1016\/j.ijcard.2019.09.053_bib45","first-page":"435","article-title":"Rapid left atrial appendage thrombus formation before suture ligation with LARIAT","volume":"14","author":"Bartu\u015b","year":"2018","journal-title":"Post\u0119py Kardiol Interwencyjnej"},{"issue":"7","key":"10.1016\/j.ijcard.2019.09.053_bib46","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.hrthm.2015.03.020","article-title":"Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: understanding the differences in the location and type of leaks and their clinical implications","volume":"12","author":"Pillarisetti","year":"2015","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.ijcard.2019.09.053_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jacep.2015.08.005","article-title":"Left atrial appendage ligation in nonvalvular atrial fibrillation patients at high risk for embolic events with ineligibility for oral anticoagulation: initial report of clinical outcomes","volume":"1","author":"Sievert","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.053_bib48","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jth.13595","article-title":"Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation","volume":"15","author":"Achilles","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.ijcard.2019.09.053_bib49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10557-017-6732-3","article-title":"Argatroban attenuates diabetic cardiomyopathy in rats by reducing fibrosis, inflammation, apoptosis, and protease-activated receptor expression","volume":"31","author":"Bulani","year":"2017","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319340173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319340173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:44:40Z","timestamp":1759092280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319340173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":49,"alternative-id":["S0167527319340173"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.053","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation factors and fibrinolytic activity in the left atrial appendage and other heart chambers in patients with atrial fibrillation: is there a local intracardiac prothrombotic state? (HEART-CLOT study)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}